Puma Biotechnology (PBYI) PT Set at $95.00 by Stifel Nicolaus
Puma Biotechnology logo Puma Biotechnology (NASDAQ:PBYI) received a $95.00 price target from equities research analysts at Stifel Nicolaus in a research note issued on Friday, March 9th. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. Stifel Nicolaus’ target price …